Juvenile Myoclonic EpilepsySymptoms, Doctors, Treatments, Advances & More
Juvenile Myoclonic Epilepsy Overview
Learn About Juvenile Myoclonic Epilepsy
Juvenile myoclonic epilepsy is a condition characterized by recurrent seizures (epilepsy). This condition begins in childhood or adolescence, usually between ages 12 and 18, and lasts into adulthood. The most common type of seizure in people with this condition is myoclonic seizures, which cause rapid, uncontrolled muscle jerks. People with this condition may also have generalized tonic-clonic seizures (also known as grand mal seizures), which cause muscle rigidity, convulsions, and loss of consciousness. Sometimes, affected individuals have absence seizures, which cause loss of consciousness for a short period that appears as a staring spell. Typically, people with juvenile myoclonic epilepsy develop the characteristic myoclonic seizures in adolescence, then develop generalized tonic-clonic seizures a few years later. Although seizures can happen at any time, they occur most commonly in the morning, shortly after awakening. Seizures can be triggered by a lack of sleep, extreme tiredness, stress, or alcohol consumption.
The genetics of juvenile myoclonic epilepsy are complex and not completely understood. Mutations in one of several genes can cause or increase susceptibility to this condition. The most studied of these genes are the GABRA1 gene and the EFHC1 gene, although mutations in at least three other genes have been identified in people with this condition. Many people with juvenile myoclonic epilepsy do not have mutations in any of these genes. Changes in other, unidentified genes are likely involved in this condition.
Juvenile myoclonic epilepsy affects an estimated 1 in 1,000 people worldwide. Approximately 5 percent of people with epilepsy have juvenile myoclonic epilepsy.
The inheritance pattern of juvenile myoclonic epilepsy is not completely understood. When the condition is caused by mutations in the GABRA1 gene, it is inherited in an autosomal dominant pattern, which means one copy of the altered gene in each cell is sufficient to cause the disorder. The inheritance pattern of juvenile myoclonic epilepsy caused by mutations in the EFHC1 gene is not known.
University Hospital
Aaron Struck is a Neurologist practicing medicine in Madison, Wisconsin. He has been practicing medicine for over 17 years. Dr. Struck is rated as an Elite provider by MediFind in the treatment of Juvenile Myoclonic Epilepsy. He is also highly rated in 17 other conditions, according to our data. His clinical expertise encompasses Epilepsy, Seizures, Juvenile Myoclonic Epilepsy, and Epilepsy with Myoclonic-Atonic Seizures.
Britta Wandschneider practices practicing medicine in Chalfont Saint Peter, United Kingdom. Ms. Wandschneider is rated as an Elite expert by MediFind in the treatment of Juvenile Myoclonic Epilepsy. She is also highly rated in 5 other conditions, according to our data. Her clinical expertise encompasses Juvenile Myoclonic Epilepsy, Myoclonic Epilepsy, Epilepsy with Myoclonic-Atonic Seizures, and Epilepsy.
UCL Queen Square Institute Of Neurology
Matthias Koepp practices practicing medicine in London, United Kingdom. Mr. Koepp is rated as an Elite expert by MediFind in the treatment of Juvenile Myoclonic Epilepsy. He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Epilepsy, Juvenile Myoclonic Epilepsy, Myoclonic Epilepsy, and Seizures.
Summary: The investigators are collecting genetic information through blood samples as well as clinical and EEG data from over 1000 people with Juvenile Myoclonic Epilepsy (JME) across the UK, Europe and North America. This study will draw on both existing and new samples from JME patients. These will be compared to anonymised data from samples for 2000 controls. The goal of this study is to find the genet...
Summary: The idiopathic generalized epilepsies (IGEs) have historically included the syndromes childhood absence epilepsy (CAE), juvenile absence epilepsy (JAE), juvenile myoclonic epilepsy (JME), and epilepsy with generalized tonic-clonic seizures alone (GTCA). Recognition of the IGEs is important for clinical care, as it informs diagnosis, prevents unnecessary investigation, allows optimal selection of a...
Published Date: September 01, 2015
Published By: National Institutes of Health